Results 181 to 190 of about 60,298 (290)
Psychological Morbidity and Quality of Life in Shwitra (Vitiligo) Patients
, 2023 Ketki Arun Aurangabadkar, Khimya Tinani
openalex +2 more sources
Ruxolitinib Suppresses Interferon‐γ‐Induced JAK/STAT Activation in Oral Keratinocytes
Clinical and Experimental Dental Research, Volume 12, Issue 1, February 2026.ABSTRACT Objectives The Janus kinase (JAK)/Signal Transducer and Activator of Transcription (STAT) pathway plays a crucial role in oral inflammatory diseases such as oral lichen planus (OLP) and periodontitis. Interferon‐gamma (IFN‐γ) is a cytokine that activates the JAK/STAT pathway.
Kim N. Stolte +4 more
wiley +1 more source
Serum activity of DPPIV and its expression on lymphocytes in patients with melanoma and in people with vitiligo [PDF]
, 2012 Ivana Z. Matić +14 more
openalex +1 more source
Evaluation of Oxidative Stress in Red Blood Cells From Vitiligo Patients and Its Correlation With Disease Severity and Activity: A Cohort Case-Control Study. [PDF]
Health Sci RepSaleh YSN +5 more
europepmc +1 more source
International Journal of Dermatology, Volume 65, Issue 2, Page 257-272, February 2026.ABSTRACT Mesenchymal stromal cells (MSCs) exert their effects primarily through paracrine signaling via soluble factors and extracellular vesicles (EVs), especially exosomes. These acellular components offer regenerative and immunomodulatory benefits with fewer safety and logistical constraints than cell‐based therapies.
Marcela da Costa Pereira Cestari +2 more
wiley +1 more source
Knowledge, Attitude, and Behavior of Photoprotection in Thai Vitiligo Patients. [PDF]
Clin Cosmet Investig DermatolWongpraparut O +5 more
europepmc +1 more source
Correction: Ruxolitinib Cream 1.5%: A Review in Non-Segmental Vitiligo [PDF]
Connie Kang
openalex +1 more source